Clinical Evaluation of Ebola Virus Disease Therapeutics
Trends in Molecular Medicine(2017)
摘要
Ebola virus disease (EVD) was first described over 40 years ago, but no treatment has been approved for humans. The 2013-2016 EVD outbreak in West Africa has expedited the clinical evaluation of several candidate therapeutics that act through different mechanisms, but with mixed results. Nevertheless, these studies are important because the accumulation of clinical data and valuable experience in conducting efficacy trials under emergency circumstances will lead to better implementation of similar studies in the future. Here, we summarize the results of EVD clinical trials, focus on the discussion of factors that may have potentially impeded the effectiveness of existing candidate therapeutics, and highlight considerations that may help meet the challenges ahead in the quest to develop clinically approved drugs.
更多查看译文
关键词
Ebola virus,therapeutics,small molecule inhibitor,convalescent plasma,monoclonal antibody
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络